|
RS189 .A568 2004eb
|
Analytical method validation and instrument performance verification / |
1 |
|
RS189 .K37 2005eb
|
Pharmaceutical drug analysis : methodology, theory, instrumentation, pharmaceutical assays, cognate assays / |
1 |
|
RS189.P66 2010
|
Practical Approaches to Method Validation and Essential Instrument Qualification. |
1 |
|
RS189 .R48 2010eb
|
Reviews in pharmaceutical and biomedical analysis / |
1 |
|
RS189 .S64 1986
|
Drug development : from laboratory to clinic / |
1 |
|
RS189 .S64 2014eb
|
Specification of drug substances and products : development and validation of analytical methods / |
1 |
|
RS189 .W46 2007eb
|
WHO Expert Committee on Specifications for Pharmaceutical Preparations : forty-first report. |
1 |
|
RS189 .W47
|
WHO Drug Information Vol. 27 No. 2 2013. |
1 |
|
RS189 .W4753 2013
|
WHO Expert Committee on Specifications for Pharmaceutical Preparations : forty-eighth report. |
1 |
|
RS189.W55 2005 RA8 .A25 no.937 RS189 .W55 2005eb
|
WHO Expert Committee on Specifications for Pharmaceutical Preparations : Fortieth Report. |
1 |
|
RS189 W56 2014
|
The Selection and Use of Essential Medicines : Report of the WHO Expert Committee 2013 (including the 18th WHO Model List of Essential Medicines and the 4th WHO Model List for Children). |
1 |
|
RS189 .W675 2013eb
|
WHO Expert Committee on Biological Standardization : sixtieth report / |
1 |
|
RS189.5.C48
|
Biomedical chromatography / |
1 |
|
RS189.5.H54
|
Principles and practices of method validation / |
1 |
|
RS189.5.H54 C48 1989
|
Chiral separations by HPLC / |
1 |
|
RS189.5.H54 L773 2005eb
|
HPLC methods for recently approved pharmaceuticals / |
1 |
|
RS189.5.H54 S26 2010eb
|
Drug monitoring by HPLC : recent developments / |
1 |
|
RS189.5.S65
|
Handbook of LC-MS bioanalysis : best practices, experimental protocols, and regulations / |
1 |
|
RS189.5.S65 C53 2011
|
Characterization of impurities and degradants using mass spectrometry / |
1 |
|
RS189.5.S65 .N57 2008
|
NMR Spectroscopy in Pharmaceutical Analysis. |
1 |